Anixa Biosciences share price logo

Anixa Biosciences

NASDAQ: ANIX

$3.60

-0.10

(-2.83%)

as on

Anixa Biosciences Stock Performance

as on August 21, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $3.55
    $3.71
    downward going graph

    1.39%

    Downside

    3.06%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.32
    $5.46
    downward going graph

    35.56%

    Downside

    51.57%

    Upside

    downward going graph

Anixa Biosciences share price movements today

Previous Close
$3.71
Open
$3.69
Volume
394.6K
Market Cap
$108.2M
Day's Low - High
$3.55 - $3.71
52 Week Low - High
$2.32 - $5.46

Anixa Biosciences Historical Returns

1 Month Return
-6.47 %
3 Month Return
+ 12.77 %
1 Year Return
+ 7.07 %
3 Year Return
-10.17 %
5 Year Return
-21.29 %

Anixa Biosciences Stock Fundamentals & Key Indicators

Check Anixa Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$108.2M

EPS (TTM)

-0.2983

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-10.73

Industry PE ratio

-3.3642857142857143

PEG Ratio

0.003923667589358671

EBITDA

-10.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-65.73%

Anixa Biosciences Stock Valuation

Track how Anixa Biosciences P/E has moved over time to understand its valuation trends.

Anixa Biosciences in the last 5 years

  • Overview

  • Trends

Lowest (-12.51x)

October 31, 2022

Today (-12.15x)

October 31, 2025

Industry (-3.36x)

October 31, 2025

Highest (-8.89x)

October 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -12.15x

Anixa Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Anixa Biosciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$108.2M-21.29%-10.730.00%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Anixa Biosciences Stock including INR - Dollar returns

The Anixa Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Anixa Biosciences investment value today

Current value as on today

₹1,33,299

Returns

₹33,299

(+33.3%)

Returns from Anixa Biosciences Stock

₹21,212 (+21.21%)

Dollar Impact

₹12,087 (+12.09%)

Analyst Recommendation on Anixa Biosciences Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Anixa Biosciences. Average target price of $10

Anixa Biosciences Share Price Target

Get share price movements and forecasts by analysts on Anixa Biosciences.

What analysts predicted

64%UPSIDE

Target Price

$10

Current Price

$3.6

Analyzed by

2 Analysts

Target

$10.00

Anixa Biosciences target price $10, a slight upside of 64% compared to current price of $3.6. According to 2 analysts rating.

Indian Investors' Interest in Anixa Biosciences Stock

Search interest for Anixa Biosciences Stock has decreased by -86% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-86% versus previous 30 day period

Anixa Biosciences Quarterly Profit & Loss

All numbers in Millions USD

Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
0
-
-
Operating Income
-3
-3
-3
-3
-3
-3
-2
-2
-2
-2
EBITDA
-3
-3
-3
-2
-3
-2
-2
-2
-2
-2
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-3
-3
-3
-2
-3
-2
-2
-2
-2
-2
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
-3
-3
-2
-3
-2
-2
-2
-2
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Anixa Biosciences Annual Profit & Loss

All numbers in Millions USD

Oct 2017
Oct 2018
Oct 2019
Oct 2020
Oct 2021
Oct 2022
Oct 2023
Oct 2024
Oct 2025
Total Revenue
0
1
0
-
0
-
0
-
-
Gross Profit
0
0
0
0
0
-
0
0
0
Operating Income
-6
-13
-11
-9
-13
-13
-11
-13
-11
EBITDA
-4
-13
-11
-10
-13
-13
-9
-12
-10
Interest Expense
0
-
-
-
0
0
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-14
-11
-10
-13
-13
-9
-12
-11
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-5
-13
-11
-10
-12
-13
-9
-12
-10
Net Profit Margin
71.16%
1.69%
33.50%
0.00%
24.80%
0.00%
23.33%
0.00%
0.00%

Anixa Biosciences Quarterly Cash Flow

All numbers in Millions USD

Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Net Income
-3
-3
-3
-2
-3
-2
-2
-2
-2
-2
Operating Cash Flow
-2
-2
-2
0
-2
-1
-1
-1
-2
-1
Investing Cash Flow
0
2
2
0
2
2
0
0
1
0
Financing Cash Flow
2
0
0
0
0
0
1
0
1
1
Change in Cash
0
0
0
0
0
0
0
0
0
0

Anixa Biosciences Annual Cash Flow

All numbers in Millions USD

Oct 2017
Oct 2018
Oct 2019
Oct 2020
Oct 2021
Oct 2022
Oct 2023
Oct 2024
Oct 2025
Net Income
-5
-14
-11
-10
-13
-13
-9
-12
-11
Operating Cash Flow
-3
-4
-4
-6
-4
-6
-6
-7
-7
Investing Cash Flow
-2
1
0
0
-3
-10
-5
4
4
Financing Cash Flow
7
2
5
9
31
0
0
3
2
Change in Cash
0
0
0
2
22
-16
-11
0
0

Mutual Funds that own Anixa Biosciences Stock

Check out the Mutual Funds with significant holdings in Anixa Biosciences.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.750206%
1275935
Fidelity Concord Street Trust
0.83697%
284763
VANGUARD INSTITUTIONAL INDEX FUNDS
0.061955%
21079
VANGUARD VALLEY FORGE FUNDS
0.052811%
17968
SCHWAB CAPITAL TRUST
0.037577%
12785

Global Institutional Holdings in Anixa Biosciences

Funds
Holdings
Vanguard
3.79%
iShares
0.32%
Kenneth Tropin
0.08%

Anixa Biosciences News & Key Events

  • img

    Today's Timeline - 16 September

    Tue, 07:10 PM

    -

    Anixa Biosciences stock has returned 51.7% this year, with EPS estimates rising 7.9% over the past three months.

    Tue, 10:00 PM

    -

    Anixa completes dosing in fourth cohort of Phase 1 ovarian cancer CAR-T trial, showing positive safety profile.

    Tue, 11:35 PM

    -

    Anixa reports improved financial performance, sufficient cash runway, and files US$200 million Shelf Registration for future funding.

Insights on Anixa Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ANIX stock has moved up by 15.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 493.6% return, outperforming this stock by 466.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 624.7% return, outperforming this stock by 620.2%

About Anixa Biosciences

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged in the development of a vaccine against breast cancer; and the development of a vaccine discovery program to develop additional cancer vaccines to address intractable cancers, including high incidence malignancies in lung, colon, and prostate. Its vaccine technologies focus on the discovery of additional retired proteins that may be associated with other forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
OrganisationAnixa Biosciences
Headquarters3150 Almaden Expressway, San Jose, CA, United States, 95118
IndustryBiotechnology
CEODr. Amit Kumar Ph.D.
E-voting on sharesClick here to vote

Key Management of Anixa Biosciences

Name

Title

Dr. Amit Kumar Ph.D.

CEO, Chairman & Co-Chair of CBAB

Mr. Michael J. Catelani CPA, MBA

President, COO, CFO & Corporate Secretary

Dr. Pamela D. Garzone Ph.D.

Chief Development Officer & Chair Breast Cancer Clinical Advisory Board

FAQs

What is Anixa Biosciences share price today?

Anixa Biosciences share price today is $3.60 as on at the close of the market. Anixa Biosciences share today touched a day high of $3.71 and a low of $3.55.

What is the 52 week high and 52 week low for Anixa Biosciences share?

Anixa Biosciences share touched a 52 week high of $5.46 on and a 52 week low of $2.32 on . Anixa Biosciences stock price today i.e. is closed at $3.60,which is 34.02% down from its 52 week high and 55.17% up from its 52 week low.

What is Anixa Biosciences's market capitalisation today?

Anixa Biosciences market capitalisation is $0.00T as on .

How to invest in Anixa Biosciences Stock (ANIX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Anixa Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Anixa Biosciences Shares that will get you 0.4167 shares as per Anixa Biosciences share price of $3.60 per share as on August 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Anixa Biosciences Stock (ANIX) from India?

Indian investors can start investing in Anixa Biosciences (ANIX) shares with as little as ₹95.695 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.95 in Anixa Biosciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Anixa Biosciences share’s latest price of $3.60 as on August 21, 2026 at 1:29 am IST, you will get 2.7778 shares of Anixa Biosciences. Learn more about fractional shares .

What are the returns that Anixa Biosciences has given to Indian investors in the last 5 years?

Anixa Biosciences stock has given -21.29% share price returns and 28.59% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?